206 related articles for article (PubMed ID: 16555306)
1. De novo ligand design to an ensemble of protein structures.
Todorov NP; Buenemann CL; Alberts IL
Proteins; 2006 Jul; 64(1):43-59. PubMed ID: 16555306
[TBL] [Abstract][Full Text] [Related]
2. Receptor flexibility in de novo ligand design and docking.
Alberts IL; Todorov NP; Dean PM
J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
[TBL] [Abstract][Full Text] [Related]
3. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Huang SY; Zou X
Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
[TBL] [Abstract][Full Text] [Related]
4. Structure-based ligand design by dynamically assembling molecular building blocks at binding site.
Liu H; Duan Z; Luo Q; Shi Y
Proteins; 1999 Sep; 36(4):462-70. PubMed ID: 10450088
[TBL] [Abstract][Full Text] [Related]
5. Exploring experimental sources of multiple protein conformations in structure-based drug design.
Damm KL; Carlson HA
J Am Chem Soc; 2007 Jul; 129(26):8225-35. PubMed ID: 17555316
[TBL] [Abstract][Full Text] [Related]
6. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
Moon JB; Howe WJ
Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
[TBL] [Abstract][Full Text] [Related]
7. An automated method for dynamic ligand design.
Miranker A; Karplus M
Proteins; 1995 Dec; 23(4):472-90. PubMed ID: 8749844
[TBL] [Abstract][Full Text] [Related]
8. E-novo: an automated workflow for efficient structure-based lead optimization.
Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
[TBL] [Abstract][Full Text] [Related]
9. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
Meagher KL; Carlson HA
J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
[TBL] [Abstract][Full Text] [Related]
10. Structural parameterization of the binding enthalpy of small ligands.
Luque I; Freire E
Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
[TBL] [Abstract][Full Text] [Related]
11. Classification of water molecules in protein binding sites.
Barillari C; Taylor J; Viner R; Essex JW
J Am Chem Soc; 2007 Mar; 129(9):2577-87. PubMed ID: 17288418
[TBL] [Abstract][Full Text] [Related]
12. Receptor flexibility in the in silico screening of reagents in the S1' pocket of human collagenase.
Källblad P; Todorov NP; Willems HM; Alberts IL
J Med Chem; 2004 May; 47(11):2761-7. PubMed ID: 15139754
[TBL] [Abstract][Full Text] [Related]
13. Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.
Chang CE; Trylska J; Tozzini V; McCammon JA
Chem Biol Drug Des; 2007 Jan; 69(1):5-13. PubMed ID: 17313452
[TBL] [Abstract][Full Text] [Related]
14. Fragment-Based flexible ligand docking by evolutionary optimization.
Budin N; Majeux N; Caflisch A
Biol Chem; 2001 Sep; 382(9):1365-72. PubMed ID: 11688719
[TBL] [Abstract][Full Text] [Related]
15. CONCERTS: dynamic connection of fragments as an approach to de novo ligand design.
Pearlman DA; Murcko MA
J Med Chem; 1996 Apr; 39(8):1651-63. PubMed ID: 8648605
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking to ensembles of protein structures.
Knegtel RM; Kuntz ID; Oshiro CM
J Mol Biol; 1997 Feb; 266(2):424-40. PubMed ID: 9047373
[TBL] [Abstract][Full Text] [Related]
17. Generation of receptor structural ensembles for virtual screening using binding site shape analysis and clustering.
Osguthorpe DJ; Sherman W; Hagler AT
Chem Biol Drug Des; 2012 Aug; 80(2):182-93. PubMed ID: 22515569
[TBL] [Abstract][Full Text] [Related]
18. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
Lu Y; Yang CY; Wang S
J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
[TBL] [Abstract][Full Text] [Related]
19. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.
Perryman AL; Lin JH; Andrew McCammon J
Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex.
Brynda J; Rezácová P; Fábry M; Horejsí M; Stouracová R; Soucek M; Hradílek M; Konvalinka J; Sedlácek J
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1943-8. PubMed ID: 15502300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
